Court Opinion

ID: 9955922
Source: CourtListenerOpinion
Date Created: 2024-03-29 18:03:56.886589+00
Date Added: 2024-06-11T08:15:39.143478
License: Public Domain

2024 IL App (4th) 220788
                                                                                   FILED
                                                                                 March 28, 2024
                                          NO. 4-22-0788
                                                                                  Carla Bender
                                                                             4 th District Appellate
                                 IN THE APPELLATE COURT                             Court, IL
                                          OF ILLINOIS

                                      FOURTH DISTRICT

In re BRITTANY F., a Person Found Subject to                )      Appeal from the
Involuntary Treatment                                       )      Circuit Court of
                                                            )      Peoria County
(The People of the State of Illinois,                       )      No. 22MH154
              Petitioner-Appellee                           )
              v.                                            )
Brittany F.,                                                )      Honorable
              Respondent-Appellant).                        )      Daniel M. Cordis,
                                                            )      Judge Presiding.

               JUSTICE KNECHT delivered the judgment of the court, with opinion.
               Justices Zenoff and Vancil concurred in the judgment and opinion.

                                            OPINION

¶1             Respondent, Brittany F., appeals from the circuit court’s order finding her subject

to involuntary treatment pursuant to section 2-107.1 of the Mental Health and Developmental

Disabilities Code (Mental Health Code) (405 ILCS 5/2-107.1 (West 2022)). On appeal, respondent

argues the court’s order should be reversed because (1) the State and the treating physician who

filed the petition for involuntary treatment failed to fulfill their pleading obligations related to

respondent having a healthcare power of attorney (POA) and (2) the State failed to prove the

benefits of the treatment plan outweighed its harms and other less restrictive services had been

explored and found inappropriate. For the reasons that follow, we reverse the court’s order.

¶2                                     I. BACKGROUND

¶3                            A. Petition for Involuntary Treatment

¶4             On August 4, 2022, Dr. Maranda Stokes, a psychiatrist at UnityPoint Health
Methodist Hospital (UnityPoint) in Peoria, Illinois, and the treating physician of respondent, filed

a petition seeking authorization for the involuntaiy treatment of respondent. Specifically, the

petition sought authorization for the involuntaiy administration of psychotropic medications and

related testing and imaging to respondent for a period of up to 90 days. The petition noted a good

faith attempt to detennine whether respondent had a healthcai·e POA had been made, and no such

POA was discovered. The petition indicated the "[p]1imaiy medication and dosage range" sought

to be administered was "[l]ithium 450mg- 1800mg per day," and, "[a]ltematively, the following

medications and dosage ranges may be administered: Please see attached list." The attached list is

as follows:

                                                  Attadlment A: S.,pplemenllry Ptlldon for A.dmlnbtratlanof Psyd,otroplc Medlcat!Oll!I for up 10 _    day,
'
    Xlndlc:11e! Cholce              8r1nd name (Seneri<I                          RDllte ofAdmlnlstrallGn                      Ooug• ll•-.e                                   Froquenq,
                                                                          Oral l90t Intramuscular {IM), IAI

             1/. .       llaldol (llalcperldolJ                          {!,Gng,attlng ln)eclable)             1-<IOlrc PO/IM; ZS-~ I.Al                        PO/IM: d1ily, L>\l: '!'ler'/ 2-4 weets

              ...;.      ProlWn (!upbmzfne HQ)                           PO; IM;IAI                           0.5-40111$ PO; 2.S-10mg IM; J.2.5.SCmg I.Al      PO/IM:clally,IAl:eYerY2-<l-ks
                         Tholllllnt (chlorproma!lne t!Ol                 PO; IM                                ~mgPOorlM                                       daily ·
               I.

              ")(
                         Rllpe~al (fisp51done) .
                         ,.,.. (J)2:'l)e(Jdoae)
                         ~vinxa (olan,aplne)
                                                                         PO; IAI
                                                                          PO; LAI
                                                                          PO;IM
                                                                                                              0.S-12mg PO; 12.S.SCmg LAI
                                                                                                               LS.12mg PO; 39-234,nglAI
                                                                                                              2.S-<!Orr,J PO and IM
                                                                                                                                                               PO: dally, IM: Ml'( 2 weeks
                                                                                                                                                             . ,o, d,Uy, IM: everyheel:s
                                                                                                                                                               dall\<
              'I.
             "-          Ahlllfy (>tlplJn!Ole)                           PO;.IM;LAI                           2.S-30mg PO; 300,Wmg IA!                         PO: d•:ly IAI: mry 4-aweel:s
                         Oour9 (cloµpile)                                 PO                                   12.5-900mg                                      daly
               ';.
                         Gtodon (zlprasldonel                            PO; IM                                I0-20Cilrc PO; 104) 1M                          daly
              '{..
             ..;._       Sen,qlltl (quetlaplot fumante)                   01'11                               2S-1200<ng                                       da.,
                         la\lld• (MraSfdor.e)                             Onl                                 20-160mg                                         daly
             '/..
             ;(_         Saphr1$(1ser0!llne)                             .Oralwb!lngyalwa/er                  S.20mg                                           dolly
                         Ut!,Jvm                                        . or.,1Table~ C.psllle, or Solin!Go    ~ISC()ng                                        dilly
             Y-
             X.          Dep1kott (dr,q:roex sodun)                       Oral ECor 24-+!our EA taliel        US-30CQl'.g                                      dally

              'j..       T~ tol{<arbamaM!~lne)                            Oral                                100-l200llc                                      c!aly
             V           T~e?III {oJlcarbazepine)                         Oral                                :J00-2400mg                                      c!ally

             X.          Atlvan (lormpam)                                 IMOJCtal                            0.S-20mg                                         dal>,,
                                                                                                              ~                                                dally
             '<          Clonopiri ( ~ l                                  Oral

            x            ~tin (bendlojllne mes)1aw)                       IMorOral                            ~                                                daily                               (

                         M ane( ~                                         Oral                                2.S-1Sn                                          claw
                         fndend (propm,ofot                               Oral                                10-l2QllJ                                        daly
                         Pro,ac (flucxetine)                              ORI                                 IQ.80111g                                        daly

                         Zolott (seitralln~Y                              Oral                                25-~                                             dait{
                         Elrelf« (Venla~ HO)                              Oral24-!!our and mndardtabftt       37.S.375mg                                      ~-
                         lll!ltlon (ml!Uzapint}                -          Oral                                7.5-6(q                                         da11'/

                                                                                      B. Disposition Repo1t

                                                                                                         -2-
¶6             On August 5, 2022, a “Disposition Report” was filed in the circuit court. The report

indicates it was prepared by a social worker. In pertinent part, the report indicates respondent’s

mother agreed with the “treatment team *** that it would be beneficial for [respondent] to be

ordered for court enforced medications.”

¶7                     C. Hearing on the Petition for Involuntary Treatment

¶8             On August 9, 2022, the circuit court conducted a hearing on the petition for

involuntary treatment. Respondent appeared with appointed counsel. She later voluntarily left, and

her presence was waived by her counsel. The State prosecuted the petition. The court heard

testimony from Dr. Stokes. Dr. Stokes was qualified as an expert witness in the field of psychiatry.

She noted it was her first time testifying in court.

¶9             According to Dr. Stokes, on July 29, 2022, respondent appeared at her mother’s

home “disorganized, acting bizarrely, [and] striking her head against the sidewalk.” Days earlier,

there were also instances of respondent exposing herself. Respondent’s mother contacted a Peoria

County crisis unit, and respondent was brought to UnityPoint. Dr. Stokes began treating

respondent on August 1, 2022.

¶ 10           Dr. Stokes reviewed respondent’s medical history. Respondent had been diagnosed

with a psychiatric illness since at least 2013. Her diagnoses included bipolar I disorder, generalized

anxiety disorder, and psychosis. Since 2013, respondent had episodes “consistent with mania,

depression.” In late March 2019, respondent was hospitalized at UnityPoint. At that time, she was

involuntarily administered per court order 600 milligrams of lithium nightly, five milligrams of

olanzapine twice daily, and melatonin. Respondent was “stabilized” on the medications and then

discharged from the hospital in mid-April 2019. Dr. Stokes noted respondent’s records mentioned

“hospitalizations at a hospital called Hartgrove” following the 2019 hospitalization at UnityPoint,

                                                 -3-
but Dr. Stokes did not have any records from that hospital and respondent was unable to provide

a related history. Respondent’s records also indicated she had followed up with a nurse practitioner

and was prescribed ziprasidone (or Geodon), methylphenidate, lorazepam, and venlafaxine. Dr.

Stokes noted respondent, as opposed to her provider, chose to discontinue taking those

medications. Dr. Stokes also noted respondent’s medical history indicated she had suffered a side

effect from ziprasidone, involuntary facial movement.

¶ 11           Dr. Stokes testified about respondent’s symptoms and behaviors since being

admitted to UnityPoint. Respondent exhibited delusions. She believed she was (1) the “Messiah,”

(2) “under astral attacks,” (3) being “injected with formaldehyde,” and (4) being poisoned through

food and water. Respondent would voluntarily drop to the ground and violently shake her body

“to shake the evil out or to stop astral attacks from happening to her.” Respondent was barely

eating, drinking, or sleeping, and she was experiencing psychological and physical distress. She

was unable to care for or protect herself.

¶ 12           Dr. Stokes opined respondent’s “symptoms [were] most consistent with [b]ipolar 1

disorder, currently manic with psychotic features.” Dr. Stokes considered partial hospitalization

and outpatient care but concluded those options would not be appropriate. She concluded treatment

with medications was appropriate. Respondent was provided with a written list of medications.

The list addressed the medications’ benefits, risks, and potential side effects. Dr. Stokes testified

respondent was unable “to participate in a meaningful conversation surrounding her diagnosis or

treatment options” and had shown a lack of understanding or insight into her situation due to her

mental illness. Respondent ultimately refused medication.

¶ 13           Dr. Stokes concluded respondent, as a result of her mental illness, lacked the

capacity to make a reasoned decision about her treatment and was in states of suffering and

                                                -4-
deterioration. Dr. Stokes also concluded the involuntary administration of psychotropic

medications and related testing and imaging to respondent for a period of up to 90 days would be

the least restrictive form of treatment. As a result, she directed her staff to file the petition for

involuntary treatment, which she signed. The petition was identified as an exhibit. Dr. Stokes

opined the medications listed in the petition would help return respondent to baseline and alleviate

her symptoms and behaviors.

¶ 14           Dr. Stokes testified respondent’s treatment would commence with the

administration of lithium and olanzapine, medications which respondent had previously tolerated

well and agreed to take upon an improvement in her symptoms. Dr. Stokes explained lithium was

a mood stabilizer, which would help with respondent’s mania, while olanzapine would help with

respondent’s psychotic symptoms. When asked about potential side effects of the two medications

being administered together, Dr. Stokes testified, “They’re commonly used together and safe to

administer together.”

¶ 15           As for the other medications listed in the petition for involuntary treatment, Dr.

Stokes explained they were selected as alternatives in the event respondent was not tolerating the

primary medications or her mania or psychotic symptoms were not resolving. Dr. Stokes indicated

the medications were generally either mood stabilizers to treat mania or antipsychotics to treat

psychotic symptoms. She explained the antipsychotics had potential metabolic and movement side

effects, while the mood stabilizers had potential metabolic, sedating, and “waking” side effects.

Dr. Stokes testified:

               “[T]he reason for the number of medications is not knowing her

               history of her other previous medication trials, it gives the

               opportunity to adequately treat her with the medication that she

                                                -5-
               tolerates. Not that we will go through that many medications, but

               that we have the option if we needed to change medications.”

She noted the medications could be changed immediately depending on the response therefrom.

Dr. Stokes opined the benefits of the treatment plan outweighed its risks.

¶ 16           At the conclusion of both the direct and cross-examinations, Dr. Stokes was asked

about respondent having a healthcare POA. On direct examination, Dr. Stokes, upon being asked

if she made a good faith attempt to determine if respondent had a healthcare POA, testified, “I

believe that we discovered recently that she does have a healthcare [POA]. I think it’s her

mother[.]” On cross-examination, Dr. Stokes, upon being asked again if respondent had a

healthcare POA, testified: “I read in the notes that her—I believe it was her mother ***. I have not

seen the document to confirm that.”

¶ 17           In closing, respondent’s counsel argued the State had not proven the benefits of the

treatment outweighed its harm because it had not elicited sufficient testimony about the alternative

medications—“you kind of need to know what [the] specific *** medications do,” “why they are

needed,” and “what their side effects are.” In so arguing, counsel acknowledged Dr. Stokes likely

included several alternatives to avoid having to file additional petitions but maintained the Mental

Health Code required an individualized treatment plan. The State, in response, argued:

               “Dr. Stokes *** testified *** [respondent] would be started on the

               lithium and [olanzapine] based on the history of these working. And,

               you know, this isn’t anything new. I mean, you know, the hospital—

               the doctor will—when we do these hearings all the time this is, you

               know, doctor—you know, these petitions always list medications,

               you know, that are intended to be used for backup purposes. So[,] I

                                               -6-
               note that there is a lot of medications listed in the petition, and I

               understand that, but when Dr. Stokes testified she is going to start

               off with lithium and [olanzapine] and if those don’t work she will

               have the option of using other medications if needed.

                      And I think *** [respondent’s counsel] may have answered

               his own question in that if you only mark those two and one of them

               doesn’t work, we are going to have to file—a new petition is going

               to be filed, and we are going to have to come back and do this all

               over again. So[,] I understand [counsel’s] concern about, you know,

               kind of the kitchen sink approach and just listing all of them. But I

               think if you look back at Dr. Stokes’ testimony, she, you know,

               starting off with lithium and [olanzapine] based on [respondent’s]

               history, this is an individualized plan and there [are] medications

               listed *** as a backup if needed. I don’t think this is anything new.

               And so, again, I just think that the benefits of this plan certainly

               outweigh the side effects. I think Dr. Stokes’ testimony is pretty

               clear on that.”

¶ 18           Based upon the evidence and arguments presented, the circuit court granted the

petition for involuntary treatment and entered an order authorizing Dr. Stokes and her staff to

involuntarily administer the identified medications and related testing and imaging to respondent

for a period not to exceed 90 days. In reaching its decision, the court, in pertinent part,

acknowledged the potential existence of a healthcare POA and noted it should be made part of the

court file following a good faith attempt to receive a copy of it. With respect to the medications

                                               -7-
sought, the court acknowledged it was “an awful lot of medications” and “Dr. Stokes didn’t talk

about each and every one and what they would do.” Even so, the court noted, it was “generally

aware and familiar with the chart and what are the antipsychotics and what are the mood

stabilizers.” It further commented:

               “[Respondent’s counsel] is not wrong when he says, yeah, but, you

               know, there should be detailed testimony about that list of

               medications in each and every single case. And there should be

               ideally. But the question is, under the statute is this an individualized

               treatment plan? And I think it is. And to create a record, I think it is

               because the doctor explained clearly what her likely—you know,

               what she is going to do in terms of giving medications and what she

               is going to do if [respondent] doesn’t tolerate the medications well

               or they are not working.”

The court acknowledged respondent had experienced a side effect of one of the alternative

medications.

¶ 19                                    D. Notice of Appeal

¶ 20           On September 1, 2022, respondent’s counsel filed a notice of appeal. Thereafter,

counsel filed in this court an unopposed motion to supplement the record with a copy of

respondent’s healthcare POA, which we granted. The POA indicates it was executed in June 2020

and respondent’s mother is the named agent. The POA provides the named agent with the authority

to, amongst other things, “decid[e] to accept, withdraw, or decline treatment for any physical or

mental health condition of mine, including life-and-death decisions.”

¶ 21           This appeal followed.

                                                 -8-
¶ 22                                     II. ANALYSIS

¶ 23           On appeal, respondent, in a 54-page appellant’s brief, argues the circuit court’s

order finding her subject to involuntary treatment should be reversed because (1) the State and Dr.

Stokes failed to fulfill their pleading obligations related to respondent having a healthcare POA

and (2) the State failed to prove the benefits of the treatment plan outweighed its harms and other

less restrictive services had been explored and found inappropriate. In so arguing, respondent

acknowledges the appeal is moot due to the expiration of the order but asserts her claims are

reviewable under the capable-of-repetition-yet-evading-review and public-interest exceptions to

the mootness doctrine.

¶ 24           In response, the State, in a six-page appellee brief, argues this appeal should be

dismissed as moot or, alternatively, “[a]ssuming that an exception to the mootness doctrine

applies,” the circuit court’s order may be reversed on two independent grounds established by

existing case law: (1) due to Dr. Stokes’s failure to attach respondent’s healthcare POA to the

petition for involuntary treatment and (2) due to the court’s authorization of the involuntary

administration of a medication known to have previously caused an adverse side effect. With

respect to its alternative argument, the State further contends, because the order may be reversed

on either of the identified grounds, this court should not consider the other claims raised by

respondent because any decision would amount to an advisory opinion and dicta.

¶ 25                                      A. Mootness

¶ 26           It is undisputed this appeal is moot. “An appeal is moot when the issues involved

in the [circuit] court no longer exist because intervening events have made it impossible for the

reviewing court to grant the complaining party effectual relief.” In re Benny M., 2017 IL 120133,

¶ 17, 104 N.E.3d 313. Here, the order authorizing the involuntary treatment of respondent expired

                                               -9-
long ago. As a result, this court cannot grant respondent effectual relief, and the appeal is moot.

See, e.g., In re Mary Ann P., 202 Ill. 2d 393, 401, 781 N.E.2d 237, 242 (2002) (finding the appeal

was moot where the involuntary treatment order had expired).

¶ 27           Despite being moot, respondent invites this court to consider this appeal and the

issues raised herein under the capable-of-repetition-yet-evading-review and public interest

exceptions to the mootness doctrine. The State provides no analysis with respect to the

applicability of these exceptions.

¶ 28           To warrant review under the capable-of-repetition-yet-evading-review exception to

the mootness doctrine, “(1) the challenged action must be too short in duration to be fully litigated

before its end, and (2) there must be a reasonable expectation that the complaining party will be

subject to the same action again.” In re Craig H., 2022 IL 126256, ¶ 20, 215 N.E.3d 143. A clear

showing of each of these elements must be made. In re J.T., 221 Ill. 2d 338, 350, 851 N.E.2d 1, 8

(2006).

¶ 29           The first element of the capable-of-repetition-yet-evading-review exception has

been met because the 90-day duration of the involuntary treatment order was too brief to allow for

appellate review. See, e.g., Craig H., 2022 IL 126256, ¶ 21. The second element of the exception

has also been met because respondent’s medical history and the actions and representations of Dr.

Stokes, the State, and the circuit court establish a reasonable expectation respondent will be subject

to the same actions again.

¶ 30           As to the second element, we recognize challenges to the sufficiency of the

evidence will ordinarily “not suffice because any subsequent case involving the respondent will

involve different evidence and will require an independent determination of the sufficiency of that

evidence.” In re Marcus S., 2022 IL App (3d) 170014, ¶ 45, 191 N.E.3d 1273 (citing In re Alfred

                                                - 10 -
H.H., 233 Ill. 2d 345, 360, 910 N.E.2d 74, 83 (2009)). The challenges to the sufficiency of the

evidence raised by respondent, however, turn on the type of evidence the State must present to

meet its statutory burden, rather than the weight of the evidence presented. And, again, the actions

and representations of Dr. Stokes, the State, and the circuit court establish a reasonable expectation

respondent will be subject to the same actions again.

¶ 31           Accordingly, we conclude respondent has shown this appeal and the issues raised

herein warrant review under the capable-of-repetition-yet-evading-review exception to the

mootness doctrine.

¶ 32           We also conclude respondent has shown this appeal and the issues raised herein

warrant review under the public-interest exception to the mootness doctrine. “The criteria for the

public interest exception are (1) the public nature of the question, (2) the desirability of an

authoritative determination for the purpose of guiding public officers, and (3) the likelihood that

the question will recur.” McHenry Township v. County of McHenry, 2022 IL 127258, ¶ 50, 201

N.E.3d 550. A clear showing of each of these elements must be made. Id.

¶ 33           The first element of the public-interest exception has been met because the

questions raised in this appeal are matters of public concern. See In re Robert S., 213 Ill. 2d 30,

46, 820 N.E.2d 424, 434 (2004) (“[T]he procedures courts must follow to authorize the involuntary

medication of mental health patients involve matters of ‘substantial public concern.’ ” (quoting

Mary Ann P., 202 Ill. 2d at 402)). The second element of the exception has also been met because

rulings on the issues presented will aid lower courts and those involved with petitions for

involuntary treatment. Last, the third and final element of the exception has been met because the

circumstances in this case are likely to recur in other involuntary-treatment cases. See, e.g., In re

A.W., 381 Ill. App. 3d 950, 955, 887 N.E.2d 831, 836 (2008).

                                                - 11 -
¶ 34           Because we conclude this appeal and the issues raised herein warrant review under

both the capable-of-repetition-yet-evading-review and public interest exceptions to the mootness

doctrine, we reject the State’s argument that this appeal should be dismissed as moot.

¶ 35           We also reject the State’s contention that, because it has identified two independent

grounds upon which it believes this court may reverse, we should not consider the other claims

raised by respondent. The State does not cite any authority supporting its contention, thereby

forfeiting it. Country Preferred Insurance Co. v. Groen, 2017 IL App (4th) 160028, ¶ 12, 69

N.E.3d 911; Ill. S. Ct. R. 341(h)(7), (i) (eff. Oct. 1, 2020). Moreover, the State’s rationale for its

contention—that any decision on the other claims would amount to an advisory opinion and

dicta—seems circular; any decision rendered under an exception to the mootness doctrine “is

essentially an advisory one.” Mary Ann P., 202 Ill. 2d at 401-02.

¶ 36                      B. Compliance With the Pleading Requirements

¶ 37           We now turn to the issues raised by respondent in this appeal. We begin with

respondent’s argument that the State and Dr. Stokes failed to fulfill their pleading obligations

related to respondent having a healthcare POA. The State’s only response to this argument is that,

in accordance with In re Denetra P., 382 Ill. App. 3d 538, 904 N.E.2d 44 (2008), reversal is

warranted due to Dr. Stokes’s failure to attach the healthcare POA to the petition.

¶ 38           As an initial matter, respondent did not raise the alleged pleading errors before the

circuit court. She nevertheless suggests the alleged errors should be reviewed on the merits or as a

matter of ineffective assistance of counsel. The State, in response, does not assert forfeiture, nor

does it address respondent’s claim of ineffective assistance. Instead, the State addresses the alleged

errors, at least in part, on the merits and concedes error warranting reversal. Based upon the

response of the State and the fact any forfeiture is a limitation on the parties and not this court, we

                                                - 12 -
will proceed with a review on the merits. See, e.g., In re Amanda H., 2017 IL App (3d) 150164,

¶ 33, 79 N.E.3d 215.

¶ 39           Respondent’s argument that the State and Dr. Stokes failed to fulfill their pleading

obligations related to respondent having a healthcare POA presents questions of law, subject to

de novo review. Marcus S., 2022 IL App (3d) 170014, ¶ 27. Specifically, respondent’s argument

presents questions as to the requirements under the statute and the impact of the failure to comply

with those requirements.

¶ 40           In this case, Dr. Stokes filed a petition seeking authorization for the involuntary

treatment of respondent pursuant to section 2-107.1 of the Mental Health Code (405 ILCS 5/2-

107.1 (West 2022)), which the State then prosecuted. Section 2-107.1(a-5)(1) states, in pertinent

part, as follows:

               “Any person 18 years of age or older, including any guardian, may

               petition the circuit court for an order authorizing the administration

               of psychotropic medication and electroconvulsive therapy to a

               recipient of services. The petition shall state that the petitioner has

               made a good faith attempt to determine whether the recipient has

               executed a power of attorney for health care under the Powers of

               Attorney for Health Care Law or a declaration for mental health

               treatment under the Mental Health             Treatment    Preference

               Declaration Act and to obtain copies of these instruments if they

               exist. If either of the above-named instruments is available to the

               petitioner, the instrument or a copy of the instrument shall be

               attached to the petition as an exhibit. The petitioner shall deliver a

                                               - 13 -
               copy of the petition, and notice of the time and place of the hearing,

               to the respondent, his or her attorney, any known agent or attorney-

               in-fact, if any, and the guardian, if any, no later than 3 days prior to

               the date of the hearing. Service of the petition and notice of the time

               and place of the hearing may be made by transmitting them via

               facsimile machine to the respondent or other party. Upon receipt of

               the petition and notice, the party served, or the person delivering the

               petition and notice to the party served, shall acknowledge service. If

               the party sending the petition and notice does not receive

               acknowledgement of service within 24 hours, service must be made

               by personal service.” Id. § 2-107.1(a-5)(1).

Section 3-101(a), in turn, requires the State to “ensure that petitions, reports[,] and orders are

properly prepared” in proceedings under section 2-107.1. Id. § 3-101(a); see In re Marcus S., 2022

IL App (3d) 160710, ¶ 32 (finding the State failed to fulfill its obligation under section 3-101(a)).

¶ 41           As it applies to this case, the plain language of the Mental Health Code required

Dr. Stokes to plead that she had made a good faith attempt to determine whether respondent had a

healthcare POA and to obtain a copy of the instrument if it existed. Dr. Stokes was further required

to (1) attach the healthcare POA or a copy thereof to the petition as an exhibit if it was available

to her and (2) deliver a copy of the petition and notice of the hearing to “any known agent or

attorney-in-fact.” The State, in turn, was required to ensure the petition filed by Dr. Stokes was

properly prepared. These are, as respondent argues and the State does not dispute, continuing

obligations under the plain language of the Mental Health Code.

¶ 42           Dr. Stokes pleaded she had made a good faith attempt to determine whether

                                                - 14 -
respondent had a healthcare POA, and no such POA was discovered. At the hearing on the petition

for involuntary treatment, the State inquired about this matter at the conclusion of its direct

examination of Dr. Stokes, presumably believing she would testify consistently with the averment

in the pleading. Dr. Stokes testified, “I believe that we discovered recently that she does have a

healthcare [POA]. I think it’s her mother[.]” On cross-examination, Dr. Stokes further explained:

“I read in the notes that her—I believe it was her mother ***. I have not seen the document to

confirm that.” There was no further inquiry of Dr. Stokes on the matter, and the petition for

involuntary treatment was not amended.

¶ 43           Under the circumstances presented, we find both Dr. Stokes and the State failed to

fulfill their pleading obligations. Sometime after the filing of the petition for involuntary treatment

but prior to the hearing on the petition, Dr. Stokes learned of new information about respondent

potentially having a healthcare POA naming her mother as the healthcare agent. The State also

became aware of this information, albeit that may not have occurred until the hearing on the

petition. Despite the new information, neither Dr. Stokes nor the State moved to amend the

allegations in the petition concerning the efforts made to determine whether respondent had a

healthcare POA and to obtain a copy of it if it existed.

¶ 44           We further find the failure of Dr. Stokes and the State to fulfill their pleading

obligations in this case cannot be said to be harmless. As our supreme court has explained,

evidence of a respondent’s wishes as expressed through a healthcare agent is “often highly relevant

to the determination of whether psychotropic medications should be administered under section 2-

107.1.” Craig H., 2022 IL 126256, ¶ 45. In this case, there were no proffers about any discussions

with respondent’s mother, the then-presumed and now-known healthcare agent of respondent. At

best, we have a statement in a report indicating respondent’s mother agreed with the “treatment

                                                - 15 -
team *** that it would be beneficial for [respondent] to be ordered for court enforced medications.”

We are not convinced this statement, by itself, is sufficient to find the failure to fulfill the pleading

obligations to be harmless.

¶ 45            Accordingly, we conclude the failure to fulfill the pleading obligations in this case

warrants a reversal of the circuit court’s order. We note this court reached a similar result in

Denetra P., 382 Ill. App. 3d at 540, where (1) the petition for involuntary treatment failed to allege

the petitioner had made a good faith attempt to determine whether the respondent had executed a

healthcare POA and (2) the respondent made averments at both trial and on appeal about the

existence of a healthcare POA. In finding for reversal, we emphasized information about the

healthcare POA was “essential” to a correct application of section 2-107.1. Id. at 545.

¶ 46            While we conclude a reversal is warranted by addressing the issue on the merits

and, thereby, obviating the need to address it as a matter of ineffective assistance, we nevertheless

emphasize it is of “paramount importance” that counsel for respondents in these type of

proceedings—as well as the circuit court—ensure all pleading obligations are met. In re Sharon

H., 2016 IL App (3d) 140980, ¶ 42, 52 N.E.3d 698.

¶ 47                              C. Proof of the Statutory Factors

¶ 48            We turn next to respondent’s argument that the State failed to prove the benefits of

the treatment plan outweighed its harms and other less restrictive services had been explored and

found inappropriate. In support of her argument, respondent emphasizes (1) the absence of

information about her healthcare POA, (2) the absence of information about all of the psychotropic

medications for which authorization to administer was sought, (3) the information about one of

the medications having previously caused an adverse side effect, and (4) the information about a

limited medication regimen having previously been administered with positive results. The State’s

                                                 - 16 -
only response to this argument is that, in accordance with In re C.S., 383 Ill. App. 3d 449, 890

N.E.2d 1007 (2008), reversal is warranted due to the authorization of the involuntary

administration of a medication known to have previously caused an adverse side effect.

¶ 49           Respondent’s argument presents challenges to the sufficiency of the evidence.

However, as previously indicated, her challenges turn on the type of evidence the State must

present to meet its statutory burden, rather than the weight of the evidence presented. Under these

circumstances, the questions for review are ones of law, which we review de novo. In re Robert

M., 2020 IL App (5th) 170015, ¶ 37, 145 N.E.3d 767.

¶ 50           The Mental Health code requires “[a] recipient of services *** be provided with

adequate and humane care and services in the least restrictive environment, pursuant to an

individual services plan.” 405 ILCS 5/2-102(a) (West 2022). Section 2-102(a-5) states, in pertinent

part, as follows:

               “If the services include the administration of electroconvulsive

               therapy or psychotropic medication, the physician or the physician’s

               designee shall advise the recipient, in writing, of the side effects,

               risks, and benefits of the treatment, as well as alternatives to the

               proposed treatment, to the extent such advice is consistent with the

               recipient’s ability to understand the information communicated. The

               physician shall determine and state in writing whether the recipient

               has the capacity to make a reasoned decision about the treatment.

               The physician or the physician’s designee shall provide to the

               recipient’s substitute decision maker, if any, the same written

               information that is required to be presented to the recipient in

                                              - 17 -
               writing. If the recipient lacks the capacity to make a reasoned

               decision about the treatment, the treatment may be administered

               only (i) pursuant to the provisions of Section 2-107 or 2-107.1 or

               (ii) pursuant to a power of attorney for health care under the Powers

               of Attorney for Health Care Law or a declaration for mental health

               treatment under the Mental Health              Treatment    Preference

               Declaration Act.” Id. § 2-102(a-5).

¶ 51           As it applies to this case, the plain language of the Mental Health Code provided

Dr. Stokes with two alternative routes to administer psychotropic medications to respondent upon

determining respondent lacked the capacity to make a reasoned decision about said treatment:

(1) with the consent of an agent named in a healthcare POA or (2) involuntarily pursuant to a court

order under section 2-107.1. See Craig H., 2022 IL 126256, ¶ 28. Dr. Stokes pursued the latter, a

pursuit that was continued by both Dr. Stokes and the State even after receiving information about

respondent having a healthcare POA.

¶ 52           As our supreme court has explained, section 2-107.1 of the Mental Health Code

(405 ILCS 5/2-107.1 (West 2022)) has been “narrowly tailored” to balance an individual’s liberty

interests with the State’s parens patriae interest in treating persons with mental illness. In re C.E.,

161 Ill. 2d 200, 218, 641 N.E.2d 345, 353 (1994). It sets forth several “factors” which must

established by “clear and convincing evidence” before any order of involuntary treatment may be

issued. 405 ILCS 5/2-107.1(a-5)(4) (West 2022). In pertinent part, the following factors must be

established: (1) “[t]hat the benefits of the treatment outweigh the harm” and (2) “[t]hat other less

restrictive services have been explored and found inappropriate.” Id. § 2-107.1(a-5)(4)(D), (F).

¶ 53           Respondent asserts the State could not prove by clear and convincing evidence that

                                                - 18 -
the benefits of the treatment outweighed the harm or that other less restrictive services had been

explored and found inappropriate without first exploring information about her healthcare POA.

We agree. As previously indicated, our supreme court has explained that evidence of a

respondent’s wishes as expressed through a healthcare agent is “often highly relevant to the

determination of whether psychotropic medications should be administered under section 2-

107.1.” Craig H., 2022 IL 126256, ¶ 45. In fact, our supreme court has specifically found the

wishes of the respondent “will often be highly pertinent to proof of these two factors.” C.E., 161

Ill. 2d at 220. Where, as here, evidence is introduced of a healthcare POA, including evidence of

the named healthcare agent, we find the State cannot prove that the benefits of the treatment

outweigh the harm or that other less restrictive services have been explored and found

inappropriate without first exploring information about the healthcare POA.

¶ 54           Respondent asserts the State could not prove by clear and convincing evidence that

the benefits of the treatment outweighed the harm without first eliciting testimony about the

benefits and potential side effects of each of the medications for which authorization to administer

was sought, as well as the benefits and potential side effects of multiple of those medications being

administered together. We agree. This court has repeatedly found “the State must produce evidence

of the benefits of each drug sought to be administered as well as the potential side effects of each

drug” in order to prove the benefits of the treatment outweigh the harm. In re Alaka W., 379 Ill.

App. 3d 251, 263, 884 N.E.2d 241, 250 (2008) (citing In re Louis S., 361 Ill. App. 3d 774, 782,

838 N.E.2d 226, 234 (2005)). Similarly, this court has also found, if the petitioner intends to

administer, or anticipates the potential administration of, medications in combination, the State

must present evidence about the benefits and potential side effects of those medications being

administered together. In re H.P., 2019 IL App (5th) 150302, ¶ 34, 130 N.E.3d 382. Contrary to

                                               - 19 -
the circuit court’s ruling in this case, producing said evidence is not just ideal, but rather, required.

Where, as here, the State fails to produce evidence of the benefits and potential side effects of each

medication sought to be administered, as well as evidence of the benefits and potential side effects

of multiple of those medications being administered together, we find the State cannot prove that

the benefits of the treatment outweighed the harm.

¶ 55            Respondent asserts, and the State concedes, the State could not prove by clear and

convincing evidence that the benefits of the treatment outweigh the harm where a medication for

which authorization to administer is sought is known to have previously caused an adverse side

effect to the recipient. We disagree. C.S., upon which both respondent and the State rely, does not

stand for such a broad proposition. In that case, the order was reversed because there was evidence

of prior adverse side effects from a medication and no evidence of its benefits. C.S., 383 Ill. App.

3d at 453. While we agree the State cannot satisfy its burden where a medication is known to have

previously caused an adverse side effect and there is no evidence of its benefits, we reject the

assertion that the State cannot prove that the benefits of the treatment outweigh the harm based

simply upon evidence of a medication having an adverse effect on the recipient.

¶ 56            Respondent asserts the State could not prove by clear and convincing evidence that

other less restrictive services had been explored and found inappropriate where there was

information about a limited medication regimen previously administered with positive results. We

disagree. It is beyond dispute the repeated administration of the same medication regimen does not

guarantee the same results. It is also beyond dispute medicine is constantly evolving. It follows

that information about a limited medication regimen previously administered with positive results

does not preclude deviation from that medication regimen. Indeed, in this case, setting aside the

other deficiencies, Dr. Stokes indicated treatment would commence with the medication regimen

                                                 - 20 -
previously administered to respondent, and she would then turn to the alternative medications in

the event respondent was not tolerating the primary medications or her mania or psychotic

symptoms were not resolving.

¶ 57             With respect to respondent’s final assertion, we agree with respondent that the

State’s characterization of the approach taken by Dr. Stokes to selecting the medications for which

she sought authorization to administer—the “kitchen sink approach”—is concerning, especially if

it is true. See 405 ILCS 5/2-102(a) (West 2022) (requiring a recipient of services “be provided

with adequate and humane care and services in the least restrictive environment, pursuant to an

individual services plan”). We also agree the sheer number of medications for which authorization

to administer was sought, even if they were alternative medications, is suspect. In any event, we

cannot definitively say the State could not have carried its burden had it presented testimony about

all of the medications for which authorization was sought. We ultimately remain confident a proper

application of the statute will prevent orders authorizing the administration of a cascade of

psychotropic medications. See Mary Ann P., 202 Ill. 2d at 412 (noting the statute’s requirements

militate against courts issuing orders permitting an unlimited number of medications to be

administered).

¶ 58             Accordingly, we conclude a reversal of the circuit court’s order is also warranted

due to the failure to prove the benefits of the treatment plan outweighed its harms and other less

restrictive services had been explored and found inappropriate.

¶ 59                                     III. CONCLUSION

¶ 60             For the reasons stated, we reverse the circuit court’s order.

¶ 61             Reversed.

                                                 - 21 -
                     In re Brittany F., 2024 IL App (4th) 220788

Decision Under Review:    Appeal from the Circuit Court of Peoria County, No. 22-MH-154;
                          the Hon. Daniel M. Cordis, Judge, presiding.

Attorneys                 Veronique Baker, Vincent Cail, Ann Krasuski, and Laurel Spahn,
for                       of Illinois Guardianship and Advocacy Commission, of Hines, for
Appellant:                appellant.

Attorneys                 Jodi M. Hoos, State’s Attorney, of Peoria (Patrick Delfino, David
for                       J. Robinson, and James Ryan Williams, of State’s Attorney’s
Appellee:                 Appellate Prosecutor’s Office, of Springfield, for the People.

                                        - 22 -